Cargando…

Identification of potential pathogenic candidates or diagnostic biomarkers in papillary thyroid carcinoma using expression and methylation profiles

The mechanisms underlying the pathogenesis of papillary thyroid carcinoma (PTC) have not yet been elucidated. The aim of the current study was to identify potential pathogenic biomarkers in PTC by comprehensively analyzing gene expression and methylation profiles, and to increase the understanding o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Songfeng, Yun, Xinwei, Ruan, Xianhui, Wei, Xi, Zheng, Xiangqian, Gao, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888281/ https://www.ncbi.nlm.nih.gov/pubmed/31814850 http://dx.doi.org/10.3892/ol.2019.11059

Ejemplares similares

LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma
por: Hou, Xiukun, et al.
Publicado: (2021)

To Explore the Inhibitory Mechanism of Quercetin in Thyroid Papillary Carcinoma through Network Pharmacology and Experiments
por: Sun, Ying, et al.
Publicado: (2022)

High expression of NUCB2 promotes papillary thyroid cancer cells proliferation and invasion
por: Zhao, Jingzhu, et al.
Publicado: (2019)

Characterization of the CpG island methylator phenotype subclass in papillary thyroid carcinoma
por: Gu, Pengfei, et al.
Publicado: (2022)

Aurora kinase a promotes the progression of papillary thyroid carcinoma by activating the mTORC2-AKT signalling pathway
por: Zhao, Zewei, et al.
Publicado: (2022)

Pharmacological inhibition of Ref-1 enhances the therapeutic sensitivity of papillary thyroid carcinoma to vemurafenib
por: Hu, Linfei, et al.
Publicado: (2022)

The mechanisms of celastrol in treating papillary thyroid carcinoma based on network pharmacology and experiment verification
por: Yi, Jiaoyu, et al.
Publicado: (2021)

Identification and validation of eight estrogen-related genes for predicting prognosis of papillary thyroid cancer
por: Zeng, Yu, et al.
Publicado: (2023)

PARP inhibitor shuts down the global translation of thyroid cancer through promoting Pol II binding to DIMT1 pause
por: Hou, Xiukun, et al.
Publicado: (2023)

Consistent analysis of differentially expressed genes across 7 cell types in papillary thyroid carcinoma
por: Ruan, Xianhui, et al.
Publicado: (2023)

Apatinib Inhibits Cell Proliferation and Induces Autophagy in Human Papillary Thyroid Carcinoma via the PI3K/Akt/mTOR Signaling Pathway
por: Meng, Xiangrui, et al.
Publicado: (2020)

Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects
por: Gu, Pengfei, et al.
Publicado: (2022)

BRAF(V600E) status and clinical characteristics in solitary and multiple papillary thyroid carcinoma: experience of 512 cases at a clinical center in China
por: Zheng, Xiangqian, et al.
Publicado: (2012)

Multi-omics profiling of papillary thyroid microcarcinoma reveals different somatic mutations and a unique transcriptomic signature
por: Li, Qiang, et al.
Publicado: (2023)

Cell-free DNA methylation biomarker for the diagnosis of papillary thyroid carcinoma
por: Hong, Shubin, et al.
Publicado: (2023)

VHL tumor suppressor as a novel potential candidate biomarker in papillary thyroid carcinoma
por: Todorović, Lidija, et al.
Publicado: (2023)

BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients
por: Wu, Yu, et al.
Publicado: (2019)

Nrf2 as a novel diagnostic biomarker for papillary thyroid carcinoma
por: Wang, Zhiyang, et al.
Publicado: (2023)

Integrated microRNA-mRNA analyses of distinct expression profiles in follicular thyroid tumors
por: Chi, Jiadong, et al.
Publicado: (2017)

Targeting Aurora-A inhibits tumor progression and sensitizes thyroid carcinoma to Sorafenib by decreasing PFKFB3-mediated glycolysis
por: Jingtai, Zhi, et al.
Publicado: (2023)

Diagnosis and treatment of ectopic thyroid carcinoma: A case report and literature review
por: Fu, Guiming, et al.
Publicado: (2022)

Expression Profile and Diagnostic Significance of MicroRNAs in Papillary Thyroid Cancer
por: Rogucki, Mariusz, et al.
Publicado: (2022)

Early Combined SHP2 Targeting Reverses the Therapeutic Resistance of Vemurafenib in Thyroid Cancer
por: Ma, Weike, et al.
Publicado: (2023)

Discovery and identification of potential biomarkers of papillary thyroid carcinoma
por: Fan, Yuxia, et al.
Publicado: (2009)

Plasma Lipidomics Profiling Reveals Biomarkers for Papillary Thyroid Cancer Diagnosis
por: Jiang, Nan, et al.
Publicado: (2021)

Identification of potential biomarkers and drugs for papillary thyroid cancer based on gene expression profile analysis
por: Qu, Ting, et al.
Publicado: (2016)

Serum biomarkers of papillary thyroid cancer
por: Makki, Fawaz M, et al.
Publicado: (2013)

Identification of candidate aberrantly methylated and differentially expressed genes in thyroid cancer
por: Tu, Yaqin, et al.
Publicado: (2018)

Relationship Between Thyroid Autoantibodies and Recurrence of Papillary Thyroid Carcinoma in Children and Adolescents
por: Huang, Dongmei, et al.
Publicado: (2022)

Detection and Identification of Serum Peptides Biomarker in Papillary Thyroid Cancer
por: Lu, Zhao-lian, et al.
Publicado: (2018)

Active surveillance as a management strategy for papillary thyroid microcarcinoma
por: Zhang, Huan, et al.
Publicado: (2020)

KCNN4 is a diagnostic and prognostic biomarker that promotes papillary thyroid cancer progression
por: Wen, Jialiang, et al.
Publicado: (2020)

Proteomic Profiling of Thyroid Papillary Carcinoma
por: Ban, Yoshiyuki, et al.
Publicado: (2012)

Proteomics profiling for the global and acetylated proteins of papillary thyroid cancers
por: Wei, Wei, et al.
Publicado: (2023)

Diagnostic value of contrast-enhanced ultrasound in papillary thyroid microcarcinoma
por: CHEN, HONG YAN, et al.
Publicado: (2016)

Mutation of Hashimoto’s Thyroiditis and Papillary Thyroid Carcinoma Related Genes and the Screening of Candidate Genes
por: Zhang, Lizhuo, et al.
Publicado: (2021)

Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma
por: Teng, Lianghong, et al.
Publicado: (2017)

Identification of Potential lncRNAs and miRNAs as Diagnostic Biomarkers for Papillary Thyroid Carcinoma Based on Machine Learning
por: Yang, Fei, et al.
Publicado: (2021)

Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma
por: Cheng, Yang, et al.
Publicado: (2019)

Transcription profiling in papillary thyroid carcinoma reveals potential diagnostic markers and drug targets
por: Filho, Mateus CB, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8m7h9pj1lgcmc1e4tk8diq3kcm